Hemant Surgical Industries Ltd
Incorporated in 1989, Hemant Surgical Industries Ltd is in the business of Medical Equipment & Supplies[1]
- Market Cap ₹ 857 Cr.
- Current Price ₹ 590
- High / Low ₹ 679 / 215
- Stock P/E 50.8
- Book Value ₹ 106
- Dividend Yield 0.00 %
- ROCE 19.2 %
- ROE 16.8 %
- Face Value ₹ 10.0
Pros
- Company's working capital requirements have reduced from 43.0 days to 24.4 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 87.9 to 106 days.
- Promoter holding has decreased over last 3 years: -20.7%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| 107 | 232 | |
| 98 | 208 | |
| Operating Profit | 9 | 24 |
| OPM % | 9% | 10% |
| 5 | 6 | |
| Interest | 2 | 4 |
| Depreciation | 1 | 2 |
| Profit before tax | 10 | 24 |
| Tax % | 23% | 23% |
| 8 | 18 | |
| EPS in Rs | 7.70 | 13.95 |
| Dividend Payout % | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 117% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 113% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 44% |
| 1 Year: | 97% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 17% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 10 | 13 |
| Reserves | 53 | 125 |
| 31 | 50 | |
| 54 | 87 | |
| Total Liabilities | 148 | 274 |
| 40 | 53 | |
| CWIP | 12 | 0 |
| Investments | 1 | 0 |
| 95 | 221 | |
| Total Assets | 148 | 274 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| 5 | -32 | |
| -30 | -3 | |
| 22 | 69 | |
| Net Cash Flow | -4 | 34 |
| Free Cash Flow | -30 | -37 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 72% | -117% |
Ratios
Consolidated / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor Days | 70 | 106 |
| Inventory Days | 208 | 121 |
| Days Payable | 188 | 146 |
| Cash Conversion Cycle | 90 | 81 |
| Working Capital Days | 62 | 24 |
| ROCE % | 19% |
Insights
In beta| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Number of manufacturing and assembly units count ・Standalone data |
|
||||||
| Number of permanent employees count ・Standalone data |
|||||||
| Top 10 customers share of revenue % of revenue ・Standalone data |
|||||||
| JMS products share of revenue % of total revenue ・Standalone data |
|||||||
| Meditape share of revenue % of revenue from operations ・Standalone data |
|||||||
| Number of international offices count ・Standalone data |
|||||||
| Number of registered products count ・Standalone data |
|||||||
Extracted by Screener AI
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
-
Shareholder Meeting / Postal Ballot-Outcome of AGM
- Hemant Surgical Industries held its 37th AGM on September 29, 2026; three resolutions were presented.
- Closure of Trading Window
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper publication regarding Notice of 37th Annual General Meeting and Remote E-voting information.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
Business Overview:[1][2]
HSIL is ISO 9001:2015, ISO 13485:2016 certified and CDSCO compliant company which deals in importing, manufacturing, and marketing medical disposable, surgical equipments and pharmaceutical products including
a) Supply of dialysis equipment, renal care, oxygen concentrators, air mattresses, ultrasound machines and digital thermometers, etc.
b) Design and manufacture of a range of nebulisers, which are
marketed under the company’s AERO brand
c) HSIL also refurbishes second-hand dialysis machines, manufactures
and supplies related accessories, dialysers and haemodialysis solutions